Chandler Gatenbee

12PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsVirtual and mixed realityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|Dec 19, 2025
Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi

|Oct 17, 2025
Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making.

Kevin R Scibilia, Kit Gallagher, M A Masud

|Aug 12, 2025
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor extinction therapy.

Kit Gallagher, Rachel S Sousa, Chandler Gatenbee

|May 02, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers.

Bina Desai, Tatiana Miti, Sandhya Prabhakaran

|May 07, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators.

Bina Desai, Tatiana Miti, Sandhya Prabhakaran

Pageof 2

Frequent Collaborators

11 joint publications

Alexander R Anderson

5 joint publications

Mark Robertson-Tessi

5 joint publications

Sandhya Prabhakaran

4 joint publications

Jeffrey West